down arrow

Hangzhou Tigermed Consulting Co., Ltd.

  • Market Cap: N/A
  • Industry: Miscellaneous
  • ISIN: CNE1000040M1
HKD
39.70
1.04 (2.69%)

Dec 12

HKG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
China Chunlai Education Group Co., Ltd.
Tianli International Holdings Ltd.
Pharmaron Beijing Co., Ltd.
China East Education Holdings Ltd.
Hangzhou Tigermed Consulting Co., Ltd.
Haitong Unitrust International Financial Leasing Co., Ltd.
YH Entertainment Group
Zonqing Environmental Ltd.
Medlive Technology Co., Ltd.
MOG Digitech Holdings Ltd.
Lepu Scientech Medical Technology (Shanghai) Co., Ltd.
Why is Hangzhou Tigermed Consulting Co., Ltd. ?
1
High Debt company with Weak Long Term Fundamental Strength
2
Negative results in Dec 23
  • DEBT-EQUITY RATIO (HY) Highest at -19.72 %
  • INTEREST COVERAGE RATIO(Q) Lowest at 1,414.19
  • RAW MATERIAL COST(Y) Grown by 9.37% (YoY)
3
With ROE of 3.55%, it has a Very Expensive valuation with a 0.25 Price to Book Value
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 13.27%, its profits have fallen by -43.2%
4
Underperformed the market in the last 1 year
  • The stock has generated a return of 13.27% in the last 1 year, much lower than market (Hang Seng Hong Kong) returns of 27.36%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Hangzhou Tigermed Consulting Co., Ltd. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Hangzhou Tigermed Consulting Co., Ltd.
13.27%
0.34
62.72%
Hang Seng Hong Kong
27.36%
1.06
25.88%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
15.78%
EBIT Growth (5y)
-10.04%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0.05
Sales to Capital Employed (avg)
0.32
Tax Ratio
54.03%
Dividend Payout Ratio
63.89%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
10.84%
ROE (avg)
7.44%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
7
Industry P/E
Price to Book Value
0.25
EV to EBIT
8.64
EV to EBITDA
5.55
EV to Capital Employed
0.27
EV to Sales
0.88
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
3.11%
ROE (Latest)
3.55%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Icon
Not enough Data to analyse Financial Trend
Icon
Not enough Data to analyse Financial Trend
Here's what is working for Hangzhou Tigermed Consulting Co., Ltd.
Depreciation
Highest at HKD 191.14 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (HKD MM)

Here's what is not working for Hangzhou Tigermed Consulting Co., Ltd.
Interest Coverage Ratio
Lowest at 1,414.19
in the last five periods
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Debt-Equity Ratio
Highest at -19.72 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Interest
Highest at HKD 72.47 MM
in the last five periods and Increased by 21.33% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (HKD MM)

Operating Profit
Lowest at HKD 1,024.88 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (HKD MM)

Operating Profit Margin
Lowest at 25.83 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Cash and Eqv
Lowest at HKD 8,258.63 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Raw Material Cost
Grown by 9.37% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Non Operating Income
Highest at HKD 0.38 MM
in the last five periods
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating income

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."